carlisle & Associates
generic drug updates News contact carlisle medical
generic drug updates
Generic Zometa® Launches
Released: 03/11/2013
By: Mike Partridge, RPh

Generic Zometa® Launches - On March 5, 2013, Sagent Pharmaceuticals received final FDA approval and launched the generic equivalent of Zometa® (zoledronic acid). Novartis' branded product had annual U.S. sales of approximately $1.2B.

Zometa® is indicated for the treatment of high blood calcium levels (hypercalcemia) that sometimes occur in patients with cancer, as well as the treatment of bone damage caused by Paget's disease, multiple myeloma, and cancers that spread to the bone.

Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer